Journal of International Psychiatry

Abstract: Objective: To investigate the clinical effect of modified electroconvulsive therapy (ECT) in children with schizophrenia and its influence on cognitive function. Methods: 90 children with schizophrenia in our hospital from March 2015 to April -2017 were randomly divided into two groups: the control group (n=45) and the observation group (n=45). The control group were given risperidone treatment, observation group were treated with modified electroconvulsive therapy, with positive and negative symptoms scale (PANSS) scale to assess the patients before and after treatment of symptoms; cognitive function in 2 groups before and after treatment were measured by event-related potentials test and eye movement, compared 2 groups of clinical curative effect and influence on cognitive function. Results: the observation group efficiency was 97.78% and 84.44% in the control group the difference was statistically significant (P<0.05); the 2 groups before treatment PANSS score had no significant difference (P>0.05); the observation group after treatment for 1 months, 2 months and 3 months PANSS score were lower than the control group (P<0.05) the 2 groups before treatment; the latency and amplitude and eye movement potentials P300 level determination of no significant difference (P>0.05); the latency and amplitude of potential P300 patients in the observation group, higher than that of the control group (P<0.05); the observation group after the treatment of eye level determination, were higher than the control group (P<0.05). Conclusion: the use of modified electroconvulsive therapy in children with schizophrenia is ideal and helpful to improve the cognitive function of the patients. It is worth popularizing.

Keywords children; schizophrenia; modified electroconvulsive therapy; Risperidone; cognitive function